Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

Related Articles by Review for PubMed (Select 11572891)

1.

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review.

de Groot K, Adu D, Savage CO; EUVAS (European vasculitis study group).

Nephrol Dial Transplant. 2001 Oct;16(10):2018-27.

2.

[Cyclophosphamide versus bolus in Wegener's granulomatosis and other ANCA-related vasculitides: advantages and disadvantages].

Reinhold-Keller E, Warnatz K.

Z Rheumatol. 2009 Jun;68(4):345-8. doi: 10.1007/s00393-008-0415-1. Review. German.

PMID:
19093127
3.

Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis.

Dhaygude A, Griffith M, Cairns T, McLean A, Palmer A, Taube D.

Nephron Clin Pract. 2004;97(4):c154-9. Review.

PMID:
15331939
4.

Interventions for renal vasculitis in adults. A systematic review.

Walters GD, Willis NS, Craig JC.

BMC Nephrol. 2010 Jun 24;11:12. doi: 10.1186/1471-2369-11-12. Review.

5.

[Treatment of ANCA-associated vascularitides].

Guillevin L, Pagnoux C.

Presse Med. 2007 May;36(5 Pt 2):922-7. Epub 2007 Apr 3. Review. French.

PMID:
17408912
6.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lee RW, D'Cruz DP.

Drugs. 2008;68(6):747-70. Review.

PMID:
18416584
7.

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA; European Vasculitis Study Group (EUVAS).

Ann Rheum Dis. 2008 Jul;67(7):1004-10. Epub 2007 Oct 2. Review.

PMID:
17911225
8.

The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.

Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS.

Health Technol Assess. 2007;11(21):iii-iv, ix-xi, 1-93. Review.

9.

[New aspects in ANCA-associated vasculitides].

Lamprecht P.

Med Klin (Munich). 2004 Sep 15;99(9):518-22. Review. German.

PMID:
15372181
10.

Adverse effects of therapy for ANCA-associated vasculitis.

Turnbull J, Harper L.

Best Pract Res Clin Rheumatol. 2009 Jun;23(3):391-401. doi: 10.1016/j.berh.2009.04.002. Review.

PMID:
19508946
11.

[ANCA-associated vasculitis].

Sinico RA, Sabadini E, Boeri R, Radice A.

G Ital Nefrol. 2002 Mar-Apr;19(2):125-36. Review. Italian.

PMID:
12195410
12.

Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies.

Goek ON, Stone JH.

Curr Opin Rheumatol. 2005 May;17(3):257-64. Review.

PMID:
15838233
13.

Review article: Progress of treatment in ANCA-associated vasculitis.

Jayne D.

Nephrology (Carlton). 2009 Feb;14(1):42-8. doi: 10.1111/j.1440-1797.2009.01101.x. Review.

PMID:
19335843
14.
15.

Immunosuppressive treatment in dialysis patients.

Altieri P, Sau G, Cao R, Barracca A, Menneas A, Micchittu B, Cabiddu G, Esposito P, Pani A.

Nephrol Dial Transplant. 2002;17 Suppl 8:2-9. Review.

16.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
17.
18.

Treatment of ANCA-associated systemic vasculitis.

Belmont HM.

Bull NYU Hosp Jt Dis. 2006;64(1-2):60-6. Review.

19.

Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis.

Harper L.

Curr Opin Rheumatol. 2010 Jan;22(1):37-42. doi: 10.1097/BOR.0b013e328331cfeb. Review.

PMID:
19770660
20.

Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.

Kamanamool N, McEvoy M, Attia J, Ingsathit A, Ngamjanyaporn P, Thakkinstian A.

Medicine (Baltimore). 2010 Jul;89(4):227-35. doi: 10.1097/MD.0b013e3181e93d00. Review.

PMID:
20616662
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk